Stock APYX APYX MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Apyx Medical Corporation

Equities

APYX

US03837C1062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
1.6 USD -3.03% Intraday chart for Apyx Medical Corporation 0.00% -38.93%
May. 09 Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024
May. 09 Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Apyx: Q1 Earnings Snapshot
AQ
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
BU
Apyx Medical Corporation Announces Board Leadership Transition
BU
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
BU
APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT
AQ
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
BU
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK
AQ
Apyx: Q4 Earnings Snapshot
AQ
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
BU
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
BU
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY SCIENTIFIC MEETING
AQ
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
BU
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY
AQ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
BU
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
BU
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
BU
Apyx: Q3 Earnings Snapshot
AQ
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
BU
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
BU
Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APYX Stock
  4. News Apyx Medical Corporation
  5. Press Releases